Bailard Inc. Purchases New Position in Clorox Co (CLX)

Bailard Inc. purchased a new position in shares of Clorox Co (NYSE:CLX) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,901 shares of the company’s stock, valued at approximately $447,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Morgan Stanley lifted its holdings in shares of Clorox by 178.2% during the 3rd quarter. Morgan Stanley now owns 3,063,813 shares of the company’s stock worth $460,828,000 after acquiring an additional 1,962,433 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Clorox by 15.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,664,803 shares of the company’s stock worth $250,403,000 after acquiring an additional 218,364 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Clorox by 5.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,019,248 shares of the company’s stock worth $153,305,000 after acquiring an additional 50,360 shares during the period. Legal & General Group Plc lifted its holdings in shares of Clorox by 7.2% during the 3rd quarter. Legal & General Group Plc now owns 821,194 shares of the company’s stock worth $123,490,000 after acquiring an additional 55,435 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Clorox by 4.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 537,337 shares of the company’s stock worth $80,817,000 after acquiring an additional 24,720 shares during the period. 82.60% of the stock is currently owned by institutional investors.

In related news, SVP Matthew T. Laszlo sold 10,585 shares of the firm’s stock in a transaction that occurred on Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total value of $1,628,925.65. Following the transaction, the senior vice president now owns 17,994 shares in the company, valued at $2,769,096.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, COO Dawn C. Willoughby sold 25,317 shares of the firm’s stock in a transaction that occurred on Monday, December 17th. The shares were sold at an average price of $160.68, for a total transaction of $4,067,935.56. Following the completion of the transaction, the chief operating officer now owns 28,244 shares in the company, valued at approximately $4,538,245.92. The disclosure for this sale can be found here. Insiders sold 249,846 shares of company stock worth $40,871,653 in the last 90 days. 1.40% of the stock is currently owned by insiders.

NYSE CLX opened at $156.31 on Thursday. Clorox Co has a one year low of $113.57 and a one year high of $167.70. The company has a debt-to-equity ratio of 3.08, a quick ratio of 0.66 and a current ratio of 1.15. The company has a market capitalization of $19.95 billion, a P/E ratio of 24.97, a price-to-earnings-growth ratio of 3.86 and a beta of 0.29.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, February 4th. The company reported $1.40 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.32 by $0.08. Clorox had a net margin of 12.65% and a return on equity of 105.97%. The firm had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same quarter last year, the firm posted $1.77 earnings per share. Clorox’s revenue for the quarter was up 4.0% compared to the same quarter last year. Equities research analysts predict that Clorox Co will post 6.33 EPS for the current year.

CLX has been the topic of several recent analyst reports. Wells Fargo & Co increased their price objective on shares of Clorox from $145.00 to $160.00 and gave the stock a “market perform” rating in a report on Wednesday, December 12th. They noted that the move was a valuation call. BMO Capital Markets set a $175.00 price objective on shares of Clorox and gave the stock a “buy” rating in a report on Tuesday, February 5th. Deutsche Bank increased their price objective on shares of Clorox from $123.00 to $124.00 and gave the stock a “sell” rating in a report on Thursday, November 1st. Citigroup increased their price objective on shares of Clorox from $149.00 to $153.00 and gave the stock a “neutral” rating in a report on Friday, November 2nd. Finally, Barclays set a $138.00 price objective on shares of Clorox and gave the stock a “hold” rating in a report on Thursday, November 1st. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $149.08.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.com-unik.info/2019/02/14/bailard-inc-purchases-new-position-in-clorox-co-clx.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: Retained Earnings

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit